Women are no more likely to use contraception after a diabetes diagnosis, according to a study published in Primary Care Diabetes. Researchers used private insurance data from nonpregnant women (aged 15-49; 2000 to 2014) to identify women with a new diabetes diagnosis (75,355 individuals) and a matched control group without diabetes (7.5 million individuals). Rates of prescription or procedural contraception use in the two groups were compared. Overall rates of contraception use did not increase in the year after diagnosis (absolute diff erence-in-diff erence, 0.4%). ere was a decline noted in estrogencontaining and injectable contraceptives in the year after diagnosis (absolute diff erence-indiff erence, −2.2% and −0.8%, respectively), although there were no corresponding increases for intrauterine contraception or subdermal implants. “Our fi ndings highlight the need for increased patient education, clinical support tools, and care coordination to improve access to family planning—including the full range of safe and eff ective contraceptive options—for women with diabetes,” the study authors write.
